Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SsK12@Lip@GSH for Radiation-Induced Oral Mucositis in Head and Neck Cancer
NCT06446180Phase 1Completed
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Jun 2024
- Primary completion
- Aug 2024
- Modality
- Yeast Strains, Targeted Liposomes, Defined Consortia
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of K12 + liposomal glutathione in oral mucositis (OM), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoint: The incidence of Severe Oral mucositis (WHO grade ≥3). Started Jun 2024; status: completed.
02
Drugs
K12 + liposomal glutathione
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT06446180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06446180.